
48. How Wearable Neurostimulation Is Changing the Future of Diabetic Foot Care
Over 500 million people worldwide live with diabetes — and half of them develop diabetic peripheral neuropathy, a condition that steals sensation, invites wounds, and too often ends in amputation. In this episode of MED Nation, Dr. Yerusalem Lanier sits down with Greta Preatoni, CEO and Co-Founder of MYNERVA Medical, an ETH Zurich spin-off developing LEIA — a wearable, AI-powered neurostimulation sock designed to restore sensation and relieve chronic pain in DPN patients without medication or surgery.Greta shares the science behind LEIA, what the clinical data is showing, and what she observed firsthand during her recent visit to the United States — including surprising differences between European and American patients. If you treat diabetic patients, love you, or are one — this episode is for you.🦶 Cutting Edge Foot and Ankle: https://cefootandankle.com 📱 Instagram: @cefootandankle🔬 Learn more about MYNERVA & LEIA: https://www.mynerva.com



